Last edition
News about "Acute Kidney Injury "
Saghmos Gets US Patent for Phase 3-Ready Cardiorenal Metabolic Modulator
Saghmos Therapeutics, Inc. has announced that the US Patent and Trademark Office (USPTO) has granted US Patent No. 11,986,473 titled, 'Prevention and/or Treatment of Contrast-Induced Acute Kidney Injury' for its Phase 3-ready product, ST-62516.
Acute Kidney Injury | 06/06/2024 | By Aishwarya | 258
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members